-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Underweight on Virtus Inv, Lowers Price Target to $168

Benzinga·12/17/2025 15:51:04
Listen to the news
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $173 to $168.